Engineered lymphocytes to treat dinitrobenzene sulphonic acid colitis in mice

European Journal of Gastroenterology and Hepatology

Volumn 15, Issue 12, 2003, Pages 1253-1255

  Felley, Christian ^a   Michetti, Pierre ^a,b  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Alpha4beta7 integrins; Inflammatory bowel diseases; Transforming growth factor beta1

Indexed keywords

ALPHA4BETA7 INTEGRIN; LYMPHOCYTE ANTIGEN; MUCOSAL ADDRESSIN CELL ADHESION MOLECULE 1; NITROBENZENE DERIVATIVE; RECOMBINANT TRANSFORMING GROWTH FACTOR BETA1; SULFONIC ACID DERIVATIVE; UNCLASSIFIED DRUG;

BIOMEDICAL ENGINEERING; CELL BASED GENE THERAPY; CHRONIC DISEASE; DISEASE SEVERITY; GASTROINTESTINAL MUCOSA; HUMAN; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; INTESTINE MUCOSA; LIGAND BINDING; LYMPHOCYTE ACTIVATION; LYMPHOCYTE HOMING; LYMPHOCYTIC COLITIS; PRIORITY JOURNAL; REVIEW; UPREGULATION;

ANIMALS; BENZENESULFONATES; COLITIS; GENE THERAPY; LYMPHOCYTE TRANSFUSION; LYMPHOCYTES; MICE; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

EID: 3943087628     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042737-200312000-00001     Document Type: Review

References (11)

1. Mowat AM. Anatomical basis of tolerance and immunity to intestinal antigens. Nat Rev Immunol 2003; 3:331-341.
2. Stagg AJ, Kamm MA, Knight SC. Intestinal dendritic cells increase T cell expression of α4β7 integrin. Eur J Immunol 2002; 32:1445-1454.
3. Wagner N, Löhler J, Kunkel EJ, Ley J, Leung E, Krinsssansen G, et al. Critical role for beta 7 integrins in formation of the gut-associated lymphoid tissue. Nature 1996; 382:366-370.
4. Groux H, Powrie F. Regulatory T cells and inflammatory bowel disease. Immunol Today 1999; 20:442-445.
5. Fedorak FN, Nielsen OH, Williams NC, Malchow H, Forbes A, Stein B, et al. Human recombinant interleukin-10 is safe and well tolerated but does not induce remission in steroid dependent Crohn's disease. Gastroenterology 2001; 120:A127.
6. Strober W, Kelsall B, Fuss I. Reciprocal IFN-γ and TGF-β responses regulate the occurrence of mucosal inflammation. Immunol Today 1997; 18:61.
7. Boirivant M, Fuss IJ, Chu A. Oxazolone colitis. A murine model of T helper cell type 2 colitis treatable with antibodies to interleukin 4. J Exp Med 1998; 188:1929-1939.
8. Castagliuolo I, Brun P, Tormen D, Palù G. Lymphocytes endowed with colon-selective homing and engineered to produce TGF-β1 prevent the development of dinitrobenzene sulphonic acid colitis. Eur J Gastroenterol Hepatol 2003; 15:1257-1265.
9. Babyatsky MW, Rossiter G, Podolsky DK. Expression of transforming growth factors α and β in colonic mucosa in inflammatory bowel disease. Gastroenterology 1996; 110:975-984.
10. Monteleone G, Kemberova A, Croft MN, McKenzie C, Steer HW, MacDonald TT. Blocking Smad7 restores TGF-β1 signaling in chronic inflammatory bowel disease. J Clin Invest 2001; 108:601-609.
11. Grant AJ, Lalor PF, Salmi M, Jalkanen S, Adams DH. Homing of mucosal lymphocytes to the liver in the pathogenesis of hepatic complications of inflammatory bowel disease. Lancet 2002; 359:150-157.